Failure to meet “clinical expectations” to blame for metal on metal hip recall says DePuy chief

The President of disgraced hip implant manufacturer DePuy has claimed that the decision to withdraw 93,000 metal on metal hip devices in August 2010 was taken on purely clinical grounds.

Andrew Ekdahl, chief of Johnson & Johnson subsidiary DePuy was testifying at the second of a possible 10,750 US trials against the J & J following high revision rates for the ASR products. The plaintiff, Carol Strum, claims that she experienced pain, suffering and financial loss as a result of being fitted with the ASR metal on metal hip device in 2008 which she then had to have removed three years later.

Depuy Metal on Metal Hip Recall – the failure rate

The company admitted to a failure rate of 13% for the ASR devices however other evidence suggests that the failure rate could have been closer to 40%. Ekdahl says that the high rate of failure led the company to take the decision to recall the devices. A document presented to the jury revealed that company officials had ticked a box listing “defection” capable of causing poor performance and ill-health as the reason for the recall. However, the attorney for J & J stated that the ASR was not defective and that there were several causes of the high failure rate.

The Johnson and Johnson recall is likely to cost the company, a world leader in health product sales, billions of dollars in damages payouts – In fact, J & J have already been forced to pay over $8.3 million in damages to an injured plaintiff following the first trial in LA.

Victim of the Metal on Metal Hip Recall? Contact our specialist solicitors

The solicitor you choose to handle your hip implant recall claim will need specialist knowledge of what can be a complicated claims process. Our medical negligence solicitors  have the expertise you need – we are already conducting over a dozen Metal on Metal Hip Recall claims against DePuy for people just like you, so:

Call 01722 422300, or

Email our team using the contact form below:

Comments or questions are welcome.

* indicates required field